Redifferentiated cardiomyocytes retain residual dedifferentiation signatures and are protected against ischaemic injury
Ontology highlight
ABSTRACT: Near-complete reversal of ERBB2-driven cardiomyocyte dedifferentiation is driven by the Hippo pathway, restoring contractility whilst long-lasting conferring cardioprotection.
INSTRUMENT(S): Q Exactive HF
ORGANISM(S): Mus Musculus (mouse)
TISSUE(S): Heart
SUBMITTER: Alon Savidor
LAB HEAD: Eldad Tzahor
PROVIDER: PXD038450 | Pride | 2023-02-01
REPOSITORIES: Pride
ACCESS DATA